Sacral nerve stimulation to treat nonobstructive urinary retention in women

Current Urology Reports

Volumn 9, Issue 5, 2008, Pages 405-411

  Comiter, Craig V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; BACLOFEN; BOTULINUM TOXIN; DIAZEPAM;

ARTICLE; BLADDER CATHETERIZATION; BLADDER FILLING; BLADDER FUNCTION; BLADDER SPHINCTER; BLEEDING; CLINICAL EFFECTIVENESS; ELECTROMYOGRAPHY; HUMAN; INDWELLING CATHETER; INFECTION COMPLICATION; INTERMITTENT CATHETERIZATION; MICTURITION; MUSCLE SPASM; NERVE STIMULATION; NEUROLOGIC EXAMINATION; NONSURGICAL INVASIVE THERAPY; PATIENT SAFETY; PUERPERIUM; SACRAL NERVE STIMULATION; TREATMENT CONTRAINDICATION; URINE RETENTION;

ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROLOGIC EXAMINATION; SACRUM; SPINAL NERVES; TREATMENT OUTCOME; URINARY RETENTION; URODYNAMICS;

EID: 51949116826     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0069-1     Document Type: Article

References (50)

1. Fowler CJ, Christmas TJ, Chappie CR, et al.: Abnormal electromyographic activity of the urethral sphincter voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ 1988, 297:1436-1438.
2. Shing-Kai Y, Kaljit S, Man-Wah P, Day L: Postpartum urinary retention. Obstet Gynecol 2005, 106:602-606.
3. Ching-Chung L, Shuenn-Dhy C, Ling-Hong T, et al.: Postpartum urinary retention: assessment of contributing factors and long-term clinical impact. Aust N Z J Obstet Gynaecol 2002, 42:365-368.
4. Groutz A, Gordon D, Wolman I, et al.: Persistent postpartum urinary retention in contemporary obstetric practice. Definition, prevalence and clinical implications. Reprod Med 2001, 46:44-48.
5. von Heyden B, Steiner T, Bothe HW, et al.: Sacral neuromodulation for urinary retention caused by sexual abuse. Psychosom Med 2001, 63:505-508.
6. Greenstein A, Matzkin H, Kaver I, et al.: Acute urinary retention in herpes genitalis infection. Urodynamic evaluation. Urology 1988, 31:453-456.
7. Smith NK, Morrant JD: Post-operative urinary retention in women: management by intermittent catheterization. Age Ageing 1990, 18:337-340.
8. DasGupta R, Fowler CJ: The management of female voiding dysfunction: Fowler's syndrome - a contemporary update. Curr Opin Urol 2003, 13:293-299.
9. Goodwin RJ, Swinn MJ, Fowler CJ: The neurophysiology of urinary retention in young women and its treatment by neuromodulation. World J Urol 1998, 16:305-307.
10. Kavia RBC, Datta SN, Dasgupta R, et al.: Urinary retention in women: its causes and management. BJU Int 2006, 97:281-297.
11. Swinn MJ, Wiseman OJ, Lowe E, et al.: The cause and natural history of isolated urinary retention in young women. J Urol 2002, 167:151-156.
12. Sullivan MP, DuBeau CE, Resnick NM, et al.: Continuous occlusion test to determine detrusor contractile performance. J Urol 1995, 154:1823-1830.
13. Wiseman OJ, Swinn JM, Brady CM, et al.: Maximum urethral closure pressure and sphincter volume in women with urinary retention. J Urol 2002, 167:1348-1352.
14. Sibel E, Taner T, Gunes K, et al.: Complete resolution of myelopathy in a patient with vitamin B12 deficiency: a case report. Internet J Neurol 2003, 2:1-11.
15. Wall LL, Addison WA: Prazosin-induced stress incontinence. Obstet Gynaecol 1990, 75:558-560.
16. Robinson D, Cardozo L, Terpstra G, et al.: A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome. BJU Int 2007, 100:840-845.
17. Hindley RG, Brierly RD, Thomas PJ: Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int 2004, 93:89-92.
18. Gallien P, Reymann JM, Amarenco G, et al.: Placebo controlled randomized, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2005, 76:1670-1676.
19. Smith CP, Nishiguchi J, O'Leary M, et al.: Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005, 65:37-41.
20. Lemack GE, Foster B, Zimmern PE: Urethral dilation in women: a questionnaire-based analysis of practice patterns. Urology 1999, 54:37-43.
21. Cain MP, Rink RC, Yerkes EB, et al.: Long-term followup and outcome of continent catheterizable vesicostomy using the Rink modification. J Urol 2002, 168:2583-2585.
22. Aboseif S, Tamaddon, K, Chaflin, S, et al.: Sacral neuromodulation in functional urinary retention: an effective way to restore voiding. BJU Int 2002, 90:662-665.
23. Yoshimura N, de Groat WC: Neural control of the lower urinary tract. Int J Urol 1997, 4:111-116.
24. de Groat WC: Central nervous system control of micturition. In Urinary Incontinence. Edited by O'Donnell PD. St. Louis, MO: Mosby; 1997:33-47.
25. de Groat WC, Nadelhaft I, Milne RJ, et al.: Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst 1981, 3:135-160.
26. Leng WW, Chancellor MB: How sacral nerve stimulation works. Urol Clin N Am 2005, 32:11-18.
27. Goodwin RJ, Swinn MJ, Fowler CJ: The neurophysiology of urinary retention in young women and its treatment by neuromodulation. World J Urol 1998, 16:305-307.
28. Fowler CJ, Christmas TJ, Chappie CR, et al.: Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction and polycystic ovaries: a new syndrome? Br Med J 1988, 297:1436-1438.
29. Schmidt RA, Senne E, Tanagho EA: Functional evaluation of sacral nerve root integrity. Report of a technique. Urology 1990, 35:388-392.
30. Schmidt RA, Vapnek JM, Tanagho EA: Restoration of voiding in chronic urinary retention using neuroprosthesis. World J Urol 1991, 9:142-144.
31. DasGupta R, Critchley HD, Dolan RJ, Fowler CJ: Changes in brain activity following sacral neuromodulation for urinary retention. J Urol 2005, 174:2268-2272.
32. Comiter, CV: Sacral neuromodulation for the symptomatic treatment of interstitial cystitis. J Urol 2003, 169:1369-1373.
33. Jarrett ME: Neuromodulation for constipation and fecal incontinence. Urol Clin North Am 2005, 32:79-87.
34. Janknegt RA, Weil EH, Eerdmans PH: Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 1997, 49:358-362.
35. Kessler TM, Madersbacher H, Kiss G: Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method? Eur Urol 2005, 47:660-665.
36. Everaerdt K, Kerckhaerdt W, Caluwaerdts H, et al.: A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol 2004, 45:649-654.
37. Jonas U, Fowler CJ, Chancellor MB: Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 2001, 165:15-19.
38. Dasgupta R, Wiseman OJ, Kitchen N, Fowler C: Long-term results of sacral neuromodulation for women with urinary retention. BJU Int 2004, 94:335-337.
39. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al.: Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 2007, 178:2029-2034.
40. van Voskuilen A, Oerlemans DJ, Weil EH, et al.: Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. BJU Int 2007, 99:107-110.
41. Sutherland SE, Lavers A, Carlson A, et al.: Sacral nerve stimulation for voiding dysfunction: one institution's 11-year experience. Neurourol Urodyn 2007, 26:19-28.
42. Starkman, JS, Scarpero H, Milam D, et al.: Sacral neuromodulation: results from a large single institutional experience. Presented at the American Urological Association Annual Conference. Atlanta, GA; May 20-25, 2006.
43. De Ridder D, Ost D, Bruyninckx F: The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention. Eur Urol 2007, 51:229-234.
44. Garg T, Machi G, Guralnick ML, O'Connor RC: Sacral neuromodulation for urinary retention after pelvic plexus injury. Urology 2007, 70:811.e11-e12.
45. Adam RA: Urinary retention following tension-free vaginal tape successfully treated by sacral neuromodulation. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17:679-680.
46. Kacjanic E, Crivellaro S, Favro M, et al.: Sacral neuromodulation for urinary retention in a kidney-transplant patient. Urologia Internationalis, 2005, 75:187-188.
47. Goh M, Diokno AC: Sacral neuromodulation for nonobstructive urinary retention - is success predictable. J Urol 2007, 178:197-199.
48. Seif C, Eckermann J, Bross S, et al.: Findings with bilateral sacral neurostimulation: sixty-two PNE-tests in patients with neurogenic and idiopathic bladder dysfunctions. Neuromodulation 2004, 7:141-144.
49. Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE: Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol 2002, 168:2046-2050.
50. Cohen B, Tunuguntla HS, Gousse AE: Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol 2006, 175:2178-2180.